Publication | Open Access
Glasgow Prognostic Score (GPS) and Tumor Response as Biomarkers of Nivolumab Monotherapy in Third- or Later-line Setting for Advanced Gastric Cancer
21
Citations
23
References
2020
Year
We present the potential of GPS and DCBC as efficient biomarkers of nivolumab for AGC, that warrants further evaluation.
| Year | Citations | |
|---|---|---|
Page 1
Page 1